title: [Radioprotective properties of isothiourea derivatives with NO-inhibitory mechanism of action].
abstract: The study of the radioprotective activity of S-[2-alkyl (aryl) sulfonyl]-S-ethyl derivatives of (vinyl)-isothiourea in (he model of the survival of mice exposed to gamma-radiation at a dose of 10 Gy has shown that the incorporation of additional sulfur-containing groups does not increase the radioprotective properties of compounds. In contrast to aminoalkil thiols, the effectiveness of the radiation protection action of the isothiourea (ITU) derivatives studied clearly correlates with the NO-inhibitory activity. This fact allowed us to assume that the radioprotective effect of S-substituted ITU caused inhibition of the endogenous synthesis of NO, which promotes the development of circulatory hypoxia, and that a further search for the radioprotective agents in this class of chemicals should be considered as the search for effective inhibitors of NO-synthase (NOS). The theoretical analysis of the conformity of molecular structures to the composition and topology of the active center of NOS-inhibitors allowed us to prognosticate a number of new ITU derivatives with the potential NOS-inhibiting ability. As a result of further theoretical and experimental studies, four S,N-disubstituted ITU derivatives - active non-selective NOS-inhibitors, were first identified and synthesized. These compounds exhibited a pronounced and prolonged vasopressive effects at doses of 0.01-0.05 LD50/15 in the models of severe hemorrhagic and endotoxic shock, and provided 65-100% 30-day survival at doses of 0.2-0.3 LD50/15 in the mice irradiated by gamma-rays at a dose of 10 Gy (LD98/30).The findings suggest the pronounced radioprotective effect of NOS-inhibitors among the ITU-derivatives.
authors.forename: M V
authors.initials: MV
authors.lastname: Filimonova
authors.forename: S Ia
authors.initials: SIa
authors.lastname: Proskuriakov
authors.forename: L I
authors.initials: LI
authors.lastname: Shevchenko
authors.forename: A S
authors.initials: AS
authors.lastname: Shevchuk
authors.forename: G A
authors.initials: GA
authors.lastname: Lushnikova
authors.forename: V M
authors.initials: VM
authors.lastname: Makarchuk
authors.forename: E V
authors.initials: EV
authors.lastname: Arzamastsev
authors.forename: V I
authors.initials: VI
authors.lastname: Laba
authors.forename: K I
authors.initials: KI
authors.lastname: Malinovskaia
authors.forename: E L
authors.initials: EL
authors.lastname: Levitskaia
mesh_terms: D000818:Animals; D004791:Enzyme Inhibitors / Q000008:administration & dosage; D005720:Gamma Rays; D007928:Lethal Dose 50; D051379:Mice; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000378:metabolism; D011837:Radiation-Protective Agents / Q000008:administration & dosage* / Q000138:chemical synthesis; D000338:beta-Aminoethyl Isothiourea / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000138:chemical synthesis
chemical_list: D004791:Enzyme Inhibitors; D011837:Radiation-Protective Agents; D000338:beta-Aminoethyl Isothiourea; D019001:Nitric Oxide Synthase